Works matching IS 10538569 AND DT 2021 AND VI 30 AND IP 4

Results: 17

Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 492, doi. 10.1002/pds.5198
By:
- Thornton, James Douglas;
- Varisco, Tyler J.;
- Downs, Callie G.
Publication type:
Article
Reviewers of manuscripts submitted in 2020.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 525, doi. 10.1002/pds.5197
Publication type:
Article
Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 514, doi. 10.1002/pds.5195
By:
- Jakobsen, Lasse Hjort;
- Callréus, Torbjörn;
- Sessa, Maurizio;
- Jerkeman, Mats;
- Andersen, Morten;
- El‐Galaly, Tarec Christoffer
Publication type:
Article
Chronic prescription opioid use in pregnancy in the United States.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 504, doi. 10.1002/pds.5194
By:
- Straub, Loreen;
- Huybrechts, Krista F.;
- Hernandez‐Diaz, Sonia;
- Zhu, Yanmin;
- Vine, Seanna;
- Desai, Rishi J.;
- Gray, Kathryn J.;
- Bateman, Brian T.
Publication type:
Article
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 482, doi. 10.1002/pds.5191
By:
- Morales, Daniel R.;
- Macfarlane, Tatiana;
- MacDonald, Thomas M.;
- Hallas, Jesper;
- Ernst, Martin Thomsen;
- Herings, Ron M. C.;
- Smits, Elisabeth;
- Overbeek, Jetty A.;
- Mitchell, Lyn;
- Morant, Steven;
- Mackenzie, Isla;
- Doney, Alexander S. F.;
- Robertson, Chris;
- Bennie, Marion;
- Wei, Li;
- Nicholson, Lizzie;
- Morris, Carole;
- Flynn, Robert W. F.
Publication type:
Article
Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real‐world trials.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 472, doi. 10.1002/pds.5188
By:
- Requena, Gema;
- Wolf, Achim;
- Williams, Rachael;
- Dedman, Daniel;
- Quint, Jennifer K.;
- Murray‐Thomas, Tarita;
- Pimenta, Jeanne M.
Publication type:
Article
Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 462, doi. 10.1002/pds.5186
By:
- Heinig, Miriam;
- Braitmaier, Malte;
- Haug, Ulrike
Publication type:
Article
"I know my body better than you:" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 451, doi. 10.1002/pds.5183
By:
- Palmsten, Kristin;
- Bredesen, Dani;
- JaKa, Meghan M.;
- Kumar, Pritika C.;
- Ziegenfuss, Jeanette Y.;
- Kharbanda, Elyse O.
Publication type:
Article
Systematic evaluation of the efficacy‐effectiveness gap of systemic treatments in extensive disease small cell lung cancer.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 445, doi. 10.1002/pds.5179
By:
- Cramer‐van der Welle, Christine M.;
- Schramel, Franz M. N. H.;
- Peters, Bas J. M.;
- Putten, John W. G.;
- Klungel, Olaf H.;
- Groen, Harry J. M.;
- Garde, Ewoudt M. W.
Publication type:
Article
Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 520, doi. 10.1002/pds.5175
By:
- Thomas, Pepijn W. A.;
- West, Rachel L.;
- Russel, Maurice G. V. M.;
- Jansen, Jeroen M.;
- Kosse, Leanne J.;
- Jessurun, Naomi T.;
- Römkens, Tessa E. H.;
- Hoentjen, Frank
Publication type:
Article
Self‐medication practice with antimalarials & the determinants of malaria treatment‐seeking behavior among postpartum mothers in a rural community in Nigeria.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 435, doi. 10.1002/pds.5178
By:
- Iribhogbe, Osede Ignis;
- Odoya, Ebube Manfred
Publication type:
Article
The evolution of anti‐emetic prescriptions in primary care, between 2006 and 2016.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 418, doi. 10.1002/pds.5170
By:
- De Bandt, David;
- Safsaf, Sarah;
- Bourrion, Bastien;
- Francois, Mathilde
Publication type:
Article
Antidepressant use in Australia and Sweden—A cross‐country comparison.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 409, doi. 10.1002/pds.5158
By:
- Eek, Emma;
- Driel, Mieke;
- Falk, Magnus;
- Hollingworth, Samantha A.;
- Merlo, Gregory
Publication type:
Article
Antibiotic utilization within 18 community hospitals in the United States: A 5‐year analysis.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 403, doi. 10.1002/pds.5156
By:
- Thabit, Abrar K.;
- Shea, Katherine M.;
- Guzman, Oscar E.;
- Garey, Kevin W.
Publication type:
Article
Use of non‐vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 426, doi. 10.1002/pds.5124
By:
- Machado‐Alba, Jorge E.;
- Gaviria‐Mendoza, Andrés;
- Machado‐Duque, Manuel E.;
- Tovar‐Yepes, Carlos;
- Ruigómez, Ana;
- García Rodríguez, Luis Alberto
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 530, doi. 10.1002/pds.5046
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 1, doi. 10.1002/pds.5314
Publication type:
Article